(Q39060458)

8 September 2017

title

Reduction in the mean number of Plasmodium falciparum genotypes in Gambian children immunized with the malaria vaccine SPf66. (English)

1 reference

8 September 2017

main subject

Plasmodium falciparum

0 references

0 references

0 references

1 reference

1 reference

Haywood M

1

1 reference

8 September 2017

Conway DJ

2

1 reference

8 September 2017

Weiss H

3

1 reference

8 September 2017

Metzger W

4

1 reference

8 September 2017

D'Alessandro U

5

1 reference

8 September 2017

Snounou G

6

1 reference

8 September 2017

Targett G

7

1 reference

8 September 2017

Greenwood B

8

1 reference

8 September 2017

language of work or name

1 reference

1 February 1999

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

8 September 2017

published in

1 reference

8 September 2017

volume

93 Suppl 1

1 reference

8 September 2017

page(s)

65-68

1 reference

Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990330-9

7 January 2021

Immune responses to Plasmodium falciparum antigens during a malaria vaccine trial in Tanzanian children

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990330-9

7 January 2021

Naturally acquired cellular immune responses to the synthetic malarial peptide SPf66 in children in Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990330-9

7 January 2021

Analysis of multiple Plasmodium falciparum infections in Tanzanian children during the phase III trial of the malaria vaccine SPf66.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990330-9

7 January 2021

An efficacy trial of the malaria vaccine SPf66 in Gambian infants--second year of follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990330-9

7 January 2021

Different genetic characteristics of Plasmodium falciparum isolates collected during successive clinical malaria episodes in Senegalese children.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990330-9

7 January 2021

Efficacy trial of malaria vaccine SPf66 in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990330-9

7 January 2021

Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990330-9

7 January 2021

Why is malaria fever periodic? A hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990330-9

7 January 2021

A pilot safety and immunogenicity study of the malaria vaccine SPf66 in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990330-9

7 January 2021

Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990330-9

7 January 2021

Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990330-9

7 January 2021

A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990330-9

7 January 2021

Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990330-9

7 January 2021

Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990330-9

7 January 2021

10.1016/S0035-9203(99)90330-9

Identifiers

DOI

1 reference

8 September 2017

1 reference